RETRACTION article
Front. Immunol.
Sec. Inflammation
Retraction: Fexuprazan safeguards the esophagus from hydrochloric acid-induced damage by suppressing the NLRP1/Caspase-1/GSDMD pyroptotic pathway
Frontiers Media SA, Lausanne, Switzerland
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Summary
Keywords
Esophagus, Fexuprazan, hcl, NLRP1, P-CABs, pyroptosis
Received
12 February 2026
Accepted
12 February 2026
Copyright
© 2026 Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.